Semaphorins: Their Dual Role in Regulating Immune-Mediated Diseases

被引:0
|
作者
Zahava Vadasz
Elias Toubi
机构
[1] Bnai Zion Medical Center,
[2] The Rappaport Faculty of Medicine,undefined
[3] Technion,undefined
来源
Clinical Reviews in Allergy & Immunology | 2014年 / 47卷
关键词
Semaphorin 3A; Semaphorin 4A; Semaphorin 4D; Semaphorin 7A; Immune regulation; Autoimmunity;
D O I
暂无
中图分类号
学科分类号
摘要
The semaphorin family members were originally considered to play a role in neurodevelopment, angiogenesis, tumor development, and metastasis. Over the past few years, a growing body of data indicates that semaphorins are involved in the regulation of the immune system, identified in this case as the “immune semaphorins.” These semaphorins are involved in almost all phases of both normal and pathological immune responses and were demonstrated to participate in allergic diseases as well as in auto-immune pathologies. Some of them, such as semaphorin 3A (sema3A), is important in downregulating autoimmune diseases by suppressing the over-activity of both T and B cell autoimmunity. In addition, sema3A was shown to enhance the ability of T and B cell regulatory properties and by doing so to control autoimmune diseases, such as systemic lupus erythematosus. Other semaphorins, such as semaphorins 4D and 4A are important in stimulating T and B cells, thus keeping these immune responses on-going. However, when overexpressed, they can induce the induction of many immune-mediated diseases. The importance of all this is to develop targeting therapies that could possibly enhance or alternatively suppress these molecules. In this review, we will focus on several immune semaphorins—their role in immune homeostasis and in immune-mediated diseases.
引用
收藏
页码:17 / 25
页数:8
相关论文
共 50 条
  • [21] THE ROLE OF TUMOUR NECROSIS FACTOR IN THE PATHOGENESIS OF IMMUNE-MEDIATED DISEASES
    Blandizzi, C.
    Gionchetti, P.
    Armuzzi, A.
    Caporali, R.
    Chimenti, S.
    Cimaz, R.
    Cimino, L.
    Lapadula, G.
    Lionetti, P.
    Marchesoni, A.
    Marcellusi, A.
    Mennini, F. S.
    Salvarani, C.
    Girolomoni, G.
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2014, 27 : 1 - 10
  • [22] Role of monoclonal antibodies in the treatment of immune-mediated glomerular diseases
    Manrique, Joaquin
    Cravedi, Paolo
    NEFROLOGIA, 2014, 34 (03): : 388 - 397
  • [23] Role of IL-15 in immune-mediated and infectious diseases
    Di Sabatino, Antonio
    Calarota, Sandra A.
    Vidali, Francesca
    MacDonald, Thomas T.
    Corazza, Gino R.
    CYTOKINE & GROWTH FACTOR REVIEWS, 2011, 22 (01) : 19 - 33
  • [24] The role of mitochondrial fusion and fission in immune-mediated inflammatory diseases
    Fang, Yulai
    Min, Shichen
    Shen, Hong
    CELLULAR IMMUNOLOGY, 2024, 403
  • [25] Author Correction: The role of platelets in immune-mediated inflammatory diseases
    Marc Scherlinger
    Christophe Richez
    George C. Tsokos
    Eric Boilard
    Patrick Blanco
    Nature Reviews Immunology, 2023, 23 (6) : 409 - 409
  • [26] The role of semaphorins in immune responses and autoimmune rheumatic diseases
    Nishide, Masayuki
    Kumanogoh, Atsushi
    NATURE REVIEWS RHEUMATOLOGY, 2018, 14 (01) : 19 - 31
  • [27] IMMUNE-MEDIATED DISEASES OF THE DOG AND CAT .1. BASIC CONCEPTS AND THE SYSTEMIC IMMUNE-MEDIATED DISEASES
    GORMAN, NT
    WERNER, LL
    BRITISH VETERINARY JOURNAL, 1986, 142 (05): : 395 - 402
  • [28] The role of semaphorins in immune responses and autoimmune rheumatic diseases
    Masayuki Nishide
    Atsushi Kumanogoh
    Nature Reviews Rheumatology, 2018, 14 : 19 - 31
  • [29] Immune-mediated Diseases of Nervous System
    Weissert, Robert
    Schulte-Mattler, Wilhelm J.
    KLINISCHE NEUROPHYSIOLOGIE, 2014, 45 (04) : 185 - 185
  • [30] Immune-Mediated Muscle Diseases of the Horse
    Durward-Akhurst, S. A.
    Valberg, S. J.
    VETERINARY PATHOLOGY, 2018, 55 (01) : 68 - 75